London, United Kingdom

Meiragtx UK Ii Limited

USPTO Granted Patents = 7



Forward Citations = 6

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Xuecui Guo (7 out of 10 patents)

silverMedal Olivier F Danos (5 out of 7 patents)

bronzeMedal Michael J Volles (5 out of 7 patents)

4.  Alex R Boyne (4 out of 5 patents)

5.  Veronique Zennou (2 out of 3 patents)

6.  Alexandria Forbes (1 out of 2 patents)

7.  Lei Feng (1 out of 1 patent)

8.  Zhaojing Zhong (2 patents)

9.  Jonathan D Finn (1 patent)

10.  Dirk Grimm (1 patent)

11.  Susanne Anna Snoek (1 patent)

12.  Niels Broekstra (1 patent)

13.  Kathleen Börner (1 patent)

14.  Jonathan Douglas Finn (2 patents)

15.  Dirk Grimm (0 patent)


7 patents:

Company Overview
Meiragtx UK II Limited is a clinical-stage gene therapy company focused on developing potentially curative treatments for severe diseases. The company's pipeline includes therapies for rare genetic disorders such as cystic fibrosis and neurodegenerative diseases. Meiragtx UK II Limited aims to revolutionize the treatment of these conditions through innovative gene therapy approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#435 in London

#2,343 in United Kingdom

London, GB
London, United Kingdom
Forward Citations = 6

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Meiragtx UK Ii Limited. Retrieved from https://idiyas.com/company/meiragtx-uk-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…